Sulfa antibiotics.

The sulfa antibiotics are sulfonamides that carry an arylamine at the N4 position, allowing them to mimic PABA and block bacterial folate synthesis. The most prescribed example is sulfamethoxazole/trimethoprim (Bactrim, Septra). Others include sulfadiazine, sulfacetamide, and the topical agent silver sulfadiazine.

Common drugs: Sulfamethoxazole (with trimethoprim), sulfadiazine, sulfacetamide, silver sulfadiazine.
Mechanism: Inhibition of dihydropteroate synthase by mimicking PABA.
Spectrum: Broad in vitro; in clinical practice narrowed by resistance.
Synergy: With trimethoprim (which blocks the next folate-pathway enzyme), bactericidal in many organisms.

Sulfamethoxazole/trimethoprim

The dominant sulfa antibiotic in current practice is the fixed combination sulfamethoxazole/trimethoprim, sold under several brand names including Bactrim and Septra. The two drugs target consecutive steps of bacterial folate synthesis. The combination is bactericidal where each component alone is bacteriostatic. How sulfa drugs work explains the synergy.

Common indications include uncomplicated urinary tract infection (still a first-line option in many guidelines for non-pregnant adults where local resistance permits), methicillin-resistant Staphylococcus aureus skin and soft-tissue infection, treatment and prophylaxis of Pneumocystis jirovecii pneumonia (PCP / PJP), toxoplasmosis, Stenotrophomonas maltophilia infection, and prophylaxis in immunocompromised patients. Travelers' diarrhoea has been a historical use, now narrower because of resistance.

Sulfadiazine

Sulfadiazine is most often used today in combination with pyrimethamine for the treatment of Toxoplasma gondii infection — particularly in immunocompromised patients with toxoplasmic encephalitis or in congenital toxoplasmosis. Folinic acid (leucovorin) is co-prescribed to reduce hematologic toxicity from the pyrimethamine. Sulfadiazine is also used historically for prophylaxis in rheumatic fever in some patients with penicillin allergy, though the role has narrowed.

Crystalluria — formation of drug crystals in the urine — has been a recognised concern with high-dose sulfadiazine. Adequate hydration is part of routine management. Kidney effects covers it.

Sulfacetamide

Sulfacetamide is used topically. Ophthalmic preparations treat bacterial conjunctivitis and other surface eye infections. Dermatological formulations (some combined with sulfur) are used for acne and seborrheic dermatitis. Systemic absorption from topical use is limited, but allergic contact reactions can occur, and patients with severe past reactions to systemic sulfa antibiotics may be advised against topical sulfa as well.

Silver sulfadiazine

Silver sulfadiazine is a topical cream used on partial-thickness burns. The silver provides antimicrobial activity and the sulfadiazine adds further coverage. Its role in routine burn care has been debated in modern wound-management literature, but it remains widely used. It can cause local reactions and is generally avoided in patients with documented sulfa allergy where alternatives are appropriate.

Other and historical agents

A number of older sulfa antibiotics — sulfanilamide, sulfisoxazole, sulfamethizole, sulfaguanidine, sulfamerazine — saw heavy use in the mid-20th century and now appear less often in current practice. Sulfanilamide itself, the active metabolite of Prontosil, was the first sulfa drug used clinically. Its role in the 1937 Elixir Sulfanilamide disaster is part of the modern history of drug regulation. Some older sulfas remain in regional formularies and ophthalmic products.

Sulfasalazine is sometimes grouped with sulfa antibiotics because, on metabolism, it produces sulfapyridine — a fragment with an antibiotic-type arylamine. Its clinical role is in inflammatory bowel disease and rheumatology rather than infection.

Why prescribing has narrowed

Sulfa antibiotics dominated antibacterial therapy in the late 1930s and 1940s. Several developments narrowed their role: the introduction of penicillin and other β-lactams; the spread of plasmid-mediated sulfonamide resistance; the recognition of severe cutaneous adverse reactions; and the appearance of newer drug classes for many of the original indications. The drugs remain important in specific niches — uncomplicated UTI, MRSA skin infection, PCP — where they retain advantages over alternatives.

Allergy and adverse reactions

The sulfa antibiotics carry the highest rate of allergy-type reactions in the broader sulfonamide family. The most common reaction is a delayed maculopapular rash; severe cutaneous adverse reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis are recognised, rare, and important. Patients with HIV experience higher rates of cutaneous reactions to TMP-SMX than the general population; sulfa and HIV covers this. Hemolysis can occur in G6PD deficiency. Photosensitivity, mild GI upset, and a small rise in serum creatinine on TMP-SMX (often without a true fall in GFR) are common; side effects covers the full list, and kidney effects the renal points.

Sulfa antibiotic allergy is real, but the label is often vague. A "sulfa allergy" entry in a chart should prompt a careful look at the original reaction. The mislabelled allergy covers why most labels overstate risk; cross-reactivity covers what the label means for non-antibiotic sulfonamides.

Pregnancy and pediatrics

TMP-SMX use in pregnancy is shaped by two specific concerns: trimethoprim is a folate antagonist (first-trimester signal for neural tube defects in some studies) and sulfamethoxazole near term carries a theoretical risk of kernicterus in the newborn. Decisions are case-by-case; sulfa and pregnancy covers it. Pediatric use is appropriate for specific indications under pediatric care; sulfa in children covers the general principles. This site does not provide doses.